Follow
Valerio De Stefano
Valerio De Stefano
Full Professor of Hematology, Catholic University, Italy
Verified email at unicatt.it
Title
Cited by
Cited by
Year
Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial
A Palumbo, S Bringhen, T Caravita, E Merla, V Capparella, V Callea, ...
The Lancet 367 (9513), 825-831, 2006
10532006
Cardiovascular events and intensity of treatment in polycythemia vera
R Marchioli, G Finazzi, G Specchia, R Cacciola, R Cavazzina, D Cilloni, ...
New England Journal of Medicine 368 (1), 22-33, 2013
9382013
Inherited thrombophilia: pathogenesis, clinical syndromes, and management
V De Stefano, G Finazzi, PM Mannucci
BLOOD-NEW YORK- 87, 3531-3544, 1996
7411996
The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation
V De Stefano, I Martinelli, PM Mannucci, K Paciaroni, P Chiusolo, ...
New England Journal of Medicine 341 (11), 801-806, 1999
6901999
Development and validation of an International Prognostic Score of thrombosis in World Health Organization–essential thrombocythemia (IPSET-thrombosis)
T Barbui, G Finazzi, A Carobbio, J Thiele, F Passamonti, E Rumi, ...
Blood, The Journal of the American Society of Hematology 120 (26), 5128-5133, 2012
6622012
Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera or essential thrombocythemia
AM Vannucchi, E Antonioli, P Guglielmelli, A Rambaldi, G Barosi, ...
Blood, The Journal of the American Society of Hematology 110 (3), 840-846, 2007
6352007
Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families
I Martinelli, PM Mannucci, V De Stefano, E Taioli, V Rossi, F Crosti, ...
Blood, The Journal of the American Society of Hematology 92 (7), 2353-2358, 1998
5971998
Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian Registry
G Finazzi, V Brancaccio, M Moia, N Ciavarella, MG Mazzucconi, ...
The American journal of medicine 100 (5), 530-536, 1996
5651996
Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism
J Emmerich, FR Rosendaal, M Cattaneo, M Margaglione, V De Stefano, ...
Thrombosis and haemostasis 86 (09), 809-816, 2001
5412001
Leukocytosis as a major thrombotic risk factor in patients with polycythemia vera
R Landolfi, L Di Gennaro, T Barbui, V De Stefano, G Finazzi, RM Marfisi, ...
Blood 109 (6), 2446-2452, 2007
5292007
Incidence of venous thromboembolism in families with inherited thrombophilia
P Simioni, BJ Sanson, P Prandoni, D Tormene, PW Friederich, B Girolami, ...
Thrombosis and haemostasis 81 (02), 198-202, 1999
4501999
Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments
V De Stefano, T Za, E Rossi, AM Vannucchi, M Ruggeri, E Elli, C Micò, ...
haematologica 93 (3), 372-380, 2008
3962008
Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with …
M Cavo, L Pantani, MT Petrucci, F Patriarca, E Zamagni, D Donnarumma, ...
Blood, The Journal of the American Society of Hematology 120 (1), 9-19, 2012
384*2012
Prothrombin G20210A mutant genotype is a risk factor for cerebrovascular ischemic disease in young patients
V De Stefano, P Chiusolo, K Paciaroni, I Casorelli, E Rossi, M Molinari, ...
Blood, The Journal of the American Society of Hematology 91 (10), 3562-3565, 1998
3591998
Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia
F Zaja, M Baccarani, P Mazza, M Bocchia, L Gugliotta, A Zaccaria, ...
Blood, The Journal of the American Society of Hematology 115 (14), 2755-2762, 2010
3292010
A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis
F Passamonti, T Giorgino, B Mora, P Guglielmelli, E Rumi, M Maffioli, ...
Leukemia 31 (12), 2726-2731, 2017
3142017
Case-control study of the frequency of thrombophilic disorders in couples with late foetal loss and no thrombotic antecedent
JC Gris, I Quéré, F Monpeyrou, E Mercier, S Ripart-Neveu, ML Tailland, ...
Thrombosis and haemostasis 81 (06), 891-899, 1999
3021999
Epidemiology of factor V Leiden: clinical implications
V de Stefano, P Chiusolo, K Paciaroni, G Leone
Seminars in thrombosis and hemostasis 24 (04), 367-379, 1998
2861998
Screening for inherited thrombophilia: indications and therapeutic implications
V De Stefano, E Rossi, K Paciaroni, G Leone
haematologica 87 (10), 1095-1108, 2002
2822002
The risk of thrombosis in patients with acute leukemia: occurrence of thrombosis at diagnosis and during treatment
V De Stefano, F Sora, E Rossi, P Chiusolo, L Laurenti, L Fianchi, G Zini, ...
Journal of Thrombosis and Haemostasis 3 (9), 1985-1992, 2005
2802005
The system can't perform the operation now. Try again later.
Articles 1–20